Loading clinical trials...
Loading clinical trials...
A Multicenter, Randomized, Open-label, Parallel Phase 1 Comparability Study of Anifrolumab Administered Using Accessorized Pre-Filled Syringe (APFS) or Autoinjector (AI) in Healthy Volunteers
Conditions
Interventions
Anifrolumab
Autoinjector
+1 more
Locations
3
United States
Research Site
Brooklyn, Maryland, United States
Research Site
Berlin, Germany
Research Site
Harrow, United Kingdom
Start Date
March 22, 2022
Primary Completion Date
April 13, 2023
Completion Date
April 13, 2023
Last Updated
May 11, 2023
NCT07401472
NCT06852872
NCT07083414
Lead Sponsor
AstraZeneca
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions